Dr. Mohamed Elsawy graduated from the Faculty of Pharmacy, Cairo University with B.Pharm.Sc.(Hons.) in 2004. After working for one year as a licensed pharmacist, he joined the Department of Medicinal and Pharmaceutical Chemistry at the National Research Centre in Cairo as a research assistant, where he worked on the design and synthesis of GABA analogues as anti-convulsant agents under the supervision of Prof. Nabil Aboul Enein. In 2009, he started a PhD programme under the supervision of Prof. Brian Walker in the School of Pharmacy at Queen's University of Belfast, working on the design and synthesis of modified peptide analogues and peptidomimetics that were designed for targeting key protein-protein complexes implicated in cancer resistance to apoptosis. After finishing his PhD, he moved in 2013 to Bordeaux to join Dr. Ivan Huc group as a postdoctoral researcher in the Institut Européen de Chimie et Biologie at the University of Bordeaux, where he worked on the design and synthesis of aliphatic/aromatic oligoamide foldamers with helical conformations. In 2014, he joined the Polymers and Peptides Research Group to work on the design and development of peptide hydrogels for biomedical applications.